Tobacco-related diseases: The role of gender. An epidemiologic study based on data from the Copenhagen Centre for Prospective Population Studies

Danish Medical Bulletin

Volumn 47, Issue 2, 2000, Pages 115-131

  Prescott, Eva ^a,b  

^a DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; CANCER INCIDENCE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; DENMARK; GENDER; HEART INFARCTION; HOSPITAL ADMISSION; LIFE EXPECTANCY; LUNG CANCER; LUNG FUNCTION TEST; MORTALITY; QUESTIONNAIRE; REVIEW; SEX RATIO; SMOKING; SMOKING HABIT;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; DENMARK; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SMOKING; SURVIVAL RATE; TOBACCO USE DISORDER;

EID: 0034000378     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (218)

1. Prescott E, Lange P, Vestbo J. Effect of gender on hospital admissions for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population. Thorax 1997; 52: 287-9.
2. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997; 10: 822-7.
3. Prescott E, Osler M, Andersen PK, Bjerg AM, Hein HO, Borch-Johnsen K, Lange P, Schnohr P, Vestbo J. Has risk associated with smoking increased? Results from the Copenhagen Centre for Prospective Population Studies. Int J Epidemiol 1997; 26: 1214-8.
4. Prescott E, Osler M, Vestbo J. Importance of detailed adjustment for smoking when comparing morbidity and mortality in men and women in a Danish population study. Eur J Public Health 1998; 8: 166-9.
5. Prescott E, Osler M, Andersen PK, Hein HO, Borch-Johnsen K, Lange P, Schnohr P, Vestbo J. Mortality in women and men in relation to smoking, Int J Epidemiol 1998; 27: 27-32.
6. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998; 316: 1043-7.
7. Prescott E, Osler M, Hein HO, Borch-Johnsen K, Schnohr P, Vestbo J. Life expectancy in Danish women and men related to smoking habits: smoking may affect women more. J Epidemiol Community Health 1998; 52: 131-2.
8. Prescott E, Osler M, Hein HO, Borch-Johnsen K, Lange P, Schnohr P, Vestbo J. Gender and smoking-related risk of lung cancer. Epidemiology 1998; 9: 79-83.
9. Prescott E, Andersen PK, Osler M, Lange P, Vestbo J. A sensitivity analysis of secular trends in risk factors and mortality based on cohort studies. Epidemiology 1999; 10: 176-80.
10. Agarwal AK, Shah A. Menstrual-linked asthma. J Asthma 1997; 34 (6): 539-45.
11. American Thoracic Society. Lung function testins: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-18.
12. Andersen LB, Vestbo J, Juel K, Bjerg AM, Keiding N, Jensen G et al. A comparison of mortality rates in three prospective studies from Copenhagen with mortality rates in the central part of the city, and the entire country. Eur J Epidemiol 1998; 14: 579-85.
13. Andersen PK, Væth M. Statistisk analyse af overlevelsesdata ved lægevidenskabelige undersøgelser. 2nd ed. København: FADL's Forlag; 1988.
14. Anonymous. Quanjer, P.H. editor. Standardized lung function testing. European Community for Coal and Steel, Luxembourg. 1983.
15. Anonymous. SAS/STAT Software; Changes and Enhancements, Release 6.10.Cory, N.C. SAS Institute Inc. 1994.
16. Appleyard M, Hansen AT, Schnohr P, Jensen G, Nyboe J. The Copenhagen City Heart Study. A book of tables with data from the first examination (1976-78) and a 5-year follow-up (1981-83). Scand J Soc Med 1989; 170(suppl.41): 1-160.
17. Bakke PS, Baste V, Gulsvik A. Bronchial responsiveness in a Norwegian community. Am Rev Respir Dis 1991; 143: 317-22.
18. Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoke in women. Am J Obstet Gynecol 1990; 162: 502-14.
19. Basavaraj S. Smoking and loss of longevity in Canada. Can J Public Health 1993; 84(5): 341-5.
20. Benyon HLC, Garbett ND, Barnes PJ. Severe premenstrual exacerbations of asthma. Effect of intramuscular progesterone. Lancet 1988; i: 370-2.
21. Bjerregaard P, Juel K. Life expectancy and mortality. An analysis of mortality in Denmark and some European countries 1950-1990. (English summary). Copenhagen: Danish Ministry of Health; 1993.
22. Bossé R, Sparrow D, Rose CL, Weiss ST. Longitudinal effect of age and smoking cessation on pulmonary function. Am Rev Respir Dis 1981; 123: 378-81.
23. Britton J, Pavord I, Richards K, Knox A, Wahedna I, Kinnear W et al. Factors influencing the occurrence of airway hyperreactivity in the general population: the importance of atopy and airway calibre. Eur Respir J 1994; 7: 881-7.
24. Brown CA, Crombie IK, Tunstall-Pedoe H. Failure of cigarette smoking to explain international differences in mortality from chronic obstructive pulmonary disease. J Epidemiol Community Health 1994; 48: 134-9.
25. Brownson RC, Chang JC, Davis JR. Gender and histologic type variations in smoking-related risk of lung cancer. Epidemiology 1992; 3: 61-4.
26. Buczko GB, Day A, Vanderdoelen JL, Boucher R, Zamel N. Effects of cigarette smoking and short-term smoking cessation on airway responsiveness to inhaled methacholine. Am Rev Respir Dis 1984; 129: 12-4.
27. Buist AS, Ghezzo H, Anthonisen NR, Cherniack RM, Ducic S, Macklem PT et al. Relationship between the single-breath N2-test and age, sex, and smoking habit in three North American cities. Am Rev Respir Dis 1979; 120: 305-18.
28. Burney PGJ, Britton JR, Chinn S, Tattersfield AE, Papacosta AO, Kelson MC et al. Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax 1987; 42: 38-44.
29. Burr ML, Charles TJ, Roy K, Seaton A. Asthma in the elderly: an epidemiologic survey. Br Med J 1979; 1: 1041-4.
30. Burrows B, Lebowitz MD, Camilli AE, Knudson RJ. Longitudinal changes in FEV1 in adults: methodologic considerations and findings in healthy non-smokers. Am Rev Respir Dis 1986; 133: 974-80.
31. Burrows B, Bloom JW, Traver GA, Cline MG. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317: 1309-14.
32. Burrows B, Barbee RA, Cline MG, Knudson RJ, Lebowitz MD. Characteristics of asthma among elderly adults in a sample of the general population. Chest 1991; 100: 935-42.
33. Byers TE, Graham S, Haughey BP, Marshall JR, Swanson MK. Diet and lung cancer risk: findings from the Western New York Diet Study. Am J Epidemiol 1987; 125(3): 351-63.
34. Camilli AE, Burrows B, Knudson RJ, Lyle SK, Lebowitz MD. Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am Rev Respir Dis 1987; 135: 794-9.
35. Campbell AH, Carter CE, O'Connell JM, Huggins R. Factors affecting the decline of ventilatory function in chronic bronchitis. Thorax 1985; 40: 741-8.
36. Candelora EC, Stockwell HG, Armstrong AW, Pinkham PA. Dietary intake and risk of lung cancer in women who never smoked. Nutr Cancer 1992; 17(3): 263-70.
37. Carter R, Nicotra B, Huber G. Differing effects of airway obstruction on physical work capacity and ventilation in men and women with COPD. Chest 1994; 106(6): 1730-9.
38. Cerveri I, Bruschi C, Zoia MC, Zanon P, Maccarini L, Grassi M et al. Distribution of bronchial nonspecific reactivity in the general population. Chest 1988; 93: 26-30.
39. Chandler MH, Schuldheisz S, Phillips BA, Muse KN. Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors. Pharmacotherapy 1997; 17(2): 224-34.
40. Chen Y, Horne SL, Dosman JA. Increased susceptibility to lung dysfunction in female smokers. Am Rev Respir Dis 1991a; 143(6): 1224-30.
41. Chen Y, Horne SL, McDuffie HH, Dosman JA. Combined effect of grain farming and smoking on lung function and the prevalence of chronic bronchitis. Int J Epidemiol 1991b; 20(2): 416-23.
42. Clayton D, Hills M. Statistical models in epidemiology. Oxford: Oxford University Press; 1993.
43. Cox DR. Regression models and life-tables. J Roy Statist Soc 1972; B 34: 187-220.
44. Crane J, Lewis S, Slater T, Crossland L, Robson B, D'Souza W et al. The self reported prevalence of asthma symptoms amongst adult New Zealanders. N Z Med J 1994; 107: 417-21.
45. Crapo R, Morris A, Gardner R. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659-64.
46. Criqui MH, Suarez L, Barrett Connor E, McPhillips J, Wingard DL, Garland C. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community. Am J Epidemiol 1988; 128(3): 606-14.
47. Cupples LA, D'Agostino RB, Kannel WB, Wolf PA, Garrison RJ, editors. The Framingham Study: An epidemiological investigation of cardiovascular disease.Bethesda: NIH publication NO. (NIH) 87-2703; 1987. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Heart Study, 30-year follow-up, section 34: Dansk Lungemedicinsk Selskab. Spirometri. En rekommandation, 1991.
48. Davis MA, Neuhaus JM, Moritz DJ, Lein D, Barclay JD, Murphy SP. Health behaviors and survival among middle-aged and older men and women in the NHANES I Epidemiologic Follow-up Study. Prev Med 1994; 23(3): 369-76.
49. Dockery DW, Ware JH, Ferris BG, Jr., Glicksberg DS, Fay ME, Spiro A et al. Distribution of forced expiratory volume in one second and forced vital capacity in healthy, white, adult never-smokers in six U.S. cities. Am Rev Respir Dis 1985; 131: 511-20.
50. Dockery DW, Speizer FE, Ferris BG, Jr., Ware JH, Louis TA, Spiro A. Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. Am Rev Respir Dis 1988; 137: 286-92.
51. Dodge R, Burrows B. The prevalence and incidence of asthma-like symptoms in a general population sample. Am Rev Respir Dis 1980; 122: 567-75.
52. Dodge R, Cline MG, Burrows B. Comparisons of asthma, emphysema, and chronic bronchitis diagnoses in a general population sample. Am Rev Respir Dis 1986; 133: 981-6.
53. Doll R, Hill AB. Mortality in relation to smoking: ten years' observations of British Doctors. Br Med J 1964; i: 1399-410.
54. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J 1976; 2: 1525-36.
55. Doll R, Gray R, Hafner B, Peto R. Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J 1980; 280: 967-71.
56. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994; 309: 901-11.
57. Eliasson O, Scherzer HH, DeGraff AC. Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol 1986; 77: 87-94.
58. Enarson DA, Vedal S, Schulzer M, Dybuncio A, Chan-yeung M. Asthma, asthmalike symptoms, chronic bronchitis, and the degree of bronchial hyperresponsiveness in epidemiologic surveys. Am Rev Respir Dis 1987; 136: 613-7.
59. Enjeti S, Hazelwood B, Permutt S, Menkes H, Terry P. Pulmonary function in young smokers: male-female differences. Am Rev Respir Dis 1978; 118: 667-73.
60. FitzGerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic function. Am Heart J 1988; 115: 267-71.
61. Floderus B, Cederlöf R, Friberg L. Smoking and mortality: a 21-year follow-up based on the swedish twin registry. Int J Epidemiol 1988; 17: 332-40.
62. Gibbs CJ, Coutts II, Lock R, Finnegan OC, White RJ. Premenstrual exacerbation of asthma. Thorax 1984; 39: 833-6.
63. Glindmeyer HW, Diem JE, Jones RN, Weill H. Noncomparability of longitudinally and cross-sectionally determined annual change in spirometry. Am Rev Respir Dis. 1982; 125: 544-548.
64. Gold DR, Wang X, Wypij D, Speizer FE, Ware JH, Dockery DW. Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med 1996; 335(13): 931-7.
65. Goodman DE, Israel E, Rosenberg M, Johnston R, Weiss ST, Drazen JM. Influence of age, diagnosis, and gender on proper use of metered dose inhalers. Am J Respir Crit Care Med 1994; 150: 1256-61.
66. Gregg I, Clark TJH, Godfrey S, editors.Asthma. 2nd ed. Cambridge: Chapman and Hall Ltd; 1983, 11, Epidemiological aspects: 242-284.
67. Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Progress in Cardiovascular Diseases 1995; XXXVIII (No.3 (Nov/Dec)): 199-210.
68. Gyntelberg F. Koronar hjertesygdom og fysisk aktivitet, epidemiologiske studier til belysning af sammenhængen mellem fysisk aktivitet og risiko for koronar hjertesygdom. [Thesis]. 1975 Københavns Universitet.
69. Hagerup L, Schroll M, Hollnagel H, Agner E, Larsen S. The Glostrup Population Studies. Collection of epidemiological tables. Reference values for use in cardiovascular population studies. Scand J Soc Med 1981; Suppl. 20: 5-112.
70. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? [see comments]. Lancet 1994; 344(8924): 721-4.
71. Hanley SP. Asthma variation with menstruation. Br J Dis Chest 1981; 75: 306-8.
72. Harris RE, Zang EA, Anderson JI, Wynder EL. Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol 1993; 22(4): 592-9.
73. Hein HO, Suadicani P, Gyntelberg F. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: six year follow up in the Copenhagen male study. BMJ 1996; 312: 736-41.
74. Hertog MG, Krcmhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study [published erratum appears in Arch Intern Med 1995 Jur: 12; 155(11): 1184]. Arch Intern Med 1995; 155(4): 381-6.
75. Hyndman SJ, Williams DR, Merrill SL, Lipscombe JM, Palmer CR. Rates of admission to hospital for asthma [see comments]. BMJ 1994; 308: 1596-600.
76. Jaakkola MS, Jaakkola JJ, Ernst P, Becklake MR. Respiratory symptoms in young adults should not be overlooked. Am Rev Respir Dis 1993; 147: 359-66.
77. Janghorbani M, Hedley AJ, Jones RB, Zhianpour M, Gilmour WH. Gender differential in all-cause and cardiovascular disease mortality. Int J Epidemiol 1993; 22(6): 1056-63.
78. Jensen G. Epidemiology of chest pain and angina pectoris. Acta Med Scand 1983; suppl 682: 13-9.
79. Juel K. Hvorfor har danskerne problemer med middellevetiden? Ugeskr Læger 1998; 160: 6793-934.
80. Juniper EF, Kline PA, Roberts RS, Hargreave FE, Daniel EF. Airway responsiveness to mechacholine during the natural menstrual cycle and the effect of oral contraceptives. Am Rev Respir Dis 1987; 135: 1039-42.
81. Kanner RE. The relationship between airways responsiveness and chronic airflow limitation. Chest 1986; 86: 54-7.
82. Kanner RE, Connett JE, Altose MD, Buist AS, Lee WW, Tashkin DP et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med 1994; 150: 956-61.
83. Kauffmann F, Tessier J-F, Oriol P. Adult passive smoking in the home environment: a risk factor for chronic airflow limitation. Am J Epidemiol 1983; 117(3): 269-80.
84. Kennedy SM, Burrows B, Vedal S, Enarson DA, Chan-yeung M. Methacholine responsiveness among working population. Am Rev Respir Dis 1990; 142: 1377-83.
85. Kerstjens HA, Rijcken B, Schouten JP, Postma DS. Decline of FEV1 by age and smoking status: facts, figures and fallacies. Thorax 1997; 52(9): 820-7.
86. Kirchhoff M. Hjerte-karsygdommenes udbredelse. Sociale og psykosociale forskelle i risikofaktorernes fordeling. [Ph.D. dissertation]. 1986 Befolkningsundersøgelserne i Glostrup.
87. Knekt P, Jarvinen R, Seppanen R, Hellovaara M, Teppo L, Pukkala E et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 1997; 146(3): 223-30.
88. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve. Am Rev Respir Dis 1976; 113: 587-600.
89. Kongerud J, Magnus P. The changing sex ratio in mortality from asthma and chronic obstructive pulmonary disease. [Abstract] Eur Respir J 1996; 9(23): 24s
90. Korn EL, Groubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: Choice of the time-scale. Am J Epidemiol 1997; 145(1): 72-80.
91. Krasnik M, Frølund CHL, Rosenstock SJ, Franzmann M, Storm HH. Incidence of lung cancer in Denmark 1943-1986 (English summary). Ugeskr Læger 1994; 156: 3021-5.
92. LaCroix AZ, Lang J, Scherr PA, Wallace RB, Cornoni-Huntley J, Berkman L et al. Smoking and mortality among older men and women in three communities. N Engl J Med 1991; 324: 1619-25.
93. LaCroix AZ, Omenn GS. Older adults and smoking. Clin Geriatr Med 1992; 8: 69-87.
94. Lange P, Groth S, Nyboe J, Mortensen J, Appleyard M, Jensen G et al. Effects of smoking and changes in smoking habits on the decline of FEV1. Eur Respir J 1989; 2: 811-6.
95. Lange P, Groth S, Nyboe J, Mortensen J, Appleyard M, Jensen G et al. Decline of the lung function related to the type of tobacco smoked and inhalation [published erratum appears in Thorax 1990 Mar; 45(3): 240]. Thorax 1990a; 45: 22-6.
96. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990b; 45: 579-85.
97. Lange P. Development and prognosis of chronic obstructive pulmonary disease with special reference to the role of tobacco smoking. An epidemiologic study. [Thesis].1991 Københavns Universitet.
98. Lapidus L, Bengtsson C, Lindquist O, Sigurdsson JA, Rafnsson V. Smoking - a risk factor for cardiovascular disease in women? Scand J Prim Health Care 1986; 4: 219-24.
99. Leynaert B, Bosquet J, Henry C, Liard R, Neukirch F. Is bronchial hyperresponsiveness more frequent in women than in men? Am J Respir Crit Care Med 1997; 156: 1413-20.
100. Liard R, Perdrizet S, Correman J, Bidou S. Smoking and chronic respiratory symptoms: prevalence in male and female smokers. Am J Public Health 1980; 70(3): 271-3.
101. Lindenstrøm E, Boysen G, Nyboe J. Lifestyle factors and risk of cerebrovascular disease in women. Stroke 1993; 24: 1468-72.
102. Lubin J, Blot W. Assessment of lung cancer risk factors by histologie category. JNCI 1984; 73: 383-9.
103. Malo JL, Pineau L, Cartier A, Martin RR. Reference values of the provocative concentrations of methacholine that cause 6% and 20% changes in forced expiratory volume in one second in a normal population. Am Rev Respir Dis 1983; 128: 8-11.
104. Markowe HLJ, Bulpitt CJ, Shipley MJ, Rose G, Crombie DL, Fleming DM. Prognosis in adult asthma: a national study. Br Med J 1987; 295: 949-52.
105. McDuffie HH, Klaassen DJ, Dosman JA. Female-Male differences in patients with primary lung cancer. Cancer 1987; 59: 1825-30.
106. McDuffie HH, Klaassen DJ, Dosman JA. Men, women and primary lung cancer - a Saskatchewan personal interview study. J Clin Epidemiol 1991; 44: 537-44.
107. McWhorter WP, Polis MA, Kaslow RA. Occurrence, predictors, and consequences of adult asthma in NHANESI and follow-up survey. Am Rev Respir Dis. 1989; 139: 721-4.
108. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the antiestrogenic effect of cigarette smoking. N Engl J Med 1986; 315: 1305-9.
109. Michnovicz JJ, Hershcopf RJ, Haley NJ, Bradlow HL, Fishman J. Cigarette smoking alters hepatic estrogen metabolism in men: implication for atherosclerosis. Metabolism 1989; 38: 537-41.
110. Middellevetidsudvalget. Dødelighed af astma og kronisk bronkitis. Copenhagen: Sundhedsministeriet;1994.
111. Miller VT, Muesing RA, LaRosa JC. Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-4. Obstet Gynecol 1991; 77: 235-40.
112. Morabia A, Wynder EL. Cigarette smoking and lung cancer cell types. Cancer 1991; 68(9): 2074-8.
113. Morris RD, Munasinghe RL. Geographic variability in hospital admission rates for respiratory disease among the elderly in the United States. Chest 1994; 106: 1172-81.
114. Mosbech J, Jørgensen J, Madsen M, Rostgaard K, Thornberg K, Poulsen TD. Landspatientregisteret. Evaluering af datakvaliteten. (English summary). Ugeskr Læger 1995; 157: 3741-5.
115. National Board of Health. Evaluation of the National Hospital Discharge Register (in Danish). Copenhagen: Sundhedsstyrelsen;1993.
116. Neukirch F, Liard R, Cooreman J, Perdrizet S. Prevalence of respiratory symptoms in Parisian teenagers according to smoking habits. J Epidemiol Community Health 1982; 36(3): 202-4.
117. Nielsen PE, Zacho J, Olsen JA, Olsen CA. Ændringer i danskernes rygevaner 1970-1987. (English summary). Ugeskr Læger 1988; 150: 2229-33.
118. Nielsen PE, Sørensen JF. Danskernes rygevaner 1988-1993. En opfølgning af tidligere befolkningsundersøgelser. (English summary). Ugeskr Læger 1995; 157: 3451-6.
119. Njolstad I, Arnesen E, Lund Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 1996; 93(3): 450-6.
120. Nyboe J, Jensen G, Appleyard M, Schnohr P. Risk factors for acute myocardial infarction in Copenhagen. I: Hereditary, educational and socioeconomic factors. Eur Heart J 1989; 10: 910-6.
121. Nyboe J, Jensen G, Appleyard M, Schnohr P. Smoking and the risk of first acute myocardial infarction. Am Heart J 1991; 122: 438-47.
122. O'Connor GT, Sparrow D, Weiss ST. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: the Normative Aging Study. Am J Respir Crit Care Med 1995; 152: 87-92.
123. Osann KE, Anton Culver H, Kurosaki T, Taylor T. Sex differences in lung-cancer risk associated with cigarette smoking. Int J Cancer 1993; 54(1): 44-8.
124. Osborne ML, Vollmer WM, Linton KLP, Buist AS. Characteristics of patients with asthma within a large HMO. Am J Respir Crit Care Med 1998; 157: 123-8.
125. Osler M. Danskernes rygevaner. (English summary). Copenhagen: Danish Institute of Clinical Epidemiology; 1992a.
126. Osler M, Schroll M. The agreement between self-reported data on chronic diseases and a national register of patients. Eur J Public Health 1992b; 2: 113-6.
127. Osler M, Sørensen TIA, Sørensen S, Rostgaard K, Jensen G, Iversen L et al. Trends in mortality, incidence and case fatality of ischaemic heart disease in Denmark, 1982-1992. Int J Epidemiol 1996; 25: 1154-61.
128. Paoletti P, Carrozzi L, Viegi G, Modena P, Ballerin L, Di Pede C et al. Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking, and level of pulmonary function. Am J Respir Crit Care Med 1995; 151: 1770-7.
129. Parish S, Collins R, Peto R, Youngman L, Barton J, Jayne K et al. Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14000 cases and 32000 controls in the United Kingdom. BMJ 1995; 311: 471-7.
130. Parker DR, O'Connor GT, Sparrow D, Segal MR, Weiss ST. The relationship of nonspecific airway responsiveness and atopy to the rate of decline of lung function. The Normative Aging Study. Am Rev Respir Dis 1990; 141: 589-94.
131. Patrick DL, Cheadle AC, Thompson DC, Diehr PH, Koepsell TD, Kinne S. The validity of self-reported smoking: A review and meta-analysis. Am J Public Health 1994; 84: 1086-93.
132. Pauli BD, Reid RL, Munt PW, Wigle RD, Forkert L. Influence of the menstrual cycle on airway function in asthmatic and normal subjects. Am Rev Respir Dis 1989; 140: 358-62.
133. Peat JK, Salome CM, Woolcock AJ. Factors associated with bronchial hyperresponsiveness in Australian adults and children. Eur Respir J 1992: 921-9.
134. Perlman JA, Wolf PH, Ray R, Lieberknecht G. Cardiovascular risk factors, premature heart disease, and all-cause mortality in a cohort of northern California women. Am J Obstet Gynecol 1988; 158(6 Pt 2): 1568-74.
135. Peto R, Lopez AD, Boreham J, Thun M, Heath Jr C. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 339: 1268-78.
136. Peto R, Lopez AD, Boreham J, Thun M, Heath C, Jr. Mortality from smoking in developed countries, 1950-2000: indirect estimates from national vital statistics.Oxford: Oxford University Press Inc; 1994.
137. Phillips AN, Wannamethee G, Walker M, Thomson A, Smith GD. Life expectancy in men who have never smoked and those who have smoked continously: 15 year follow up of large cohort of middle-aged British men. Br Med J 1996; 313: 907-8.
138. Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CIM et al. Genetic susceptibility to asthma - bronchial hyperresponsiveness co-inherited with a major gene for atopy. N Engl J Med 1995; 333: 894-900.
139. Potter JD, Steinmetz K. Vegetables, fruit and phytoestrogens as preventive agents. IARC Sci Publ 1996(139): 61-90.
140. Prescott E, Grønbsek M, Becker U, Sørensen TIA. Alcohol and lung cancer: Influence of type of alcoholic beverage. Am J Epidemiol 1999a; 149: 463-70.
141. Prescott E, Lange P, Vestbo J, The Copenhagen City Heart Study Group. Socioeconomic status, lung function and admission to hospital for COPD. Eur Respir J 1999b; 13: 1109-14.
142. Pride NB. Bronchial hyperreactivity in smokers. Symposium report. Eur Respir J 1988; 1: 485-7.
143. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volumes and forced ventilalory flows. Eur Respir J 1993; 6 Suppl. 16. 5-40.
144. Redline S, Gold D. Challenges in interpreting gender differences in asthma. Editorial. Am J Respir Crit Care Med 1994; 150: 1219-21.
145. Rijcken B, Schouten JP, Weiss ST, Speizer FE, van der Lende R. The relationship between airway responsiveness to histamine and pulmonary function level in a random population sample. Am Rev Respir Dis 1988; 137: 826-32.
146. Rijcken B, Schouten JP, Mensinga TT, Weiss ST, de Vries K, van der Lende R. Factors associated with bronchial responsiveness to histamine in a population sample of adults. Am Rev Respir Dis 1993; 147: 1447-53.
147. Rijcken B, Schouten JP, Xu X, Rosner B, Weiss ST. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. Am J Respir Crit Care Med 1995; 151: 1377-82.
148. Rijcken B, Weiss ST. Longitudinal analyses of airway responsiveness and pulmonary function decline. Am J Respir Crit Care Med 1996; 154: 5246-9.
149. Risch HA, Howe GR, Jain M, Burch JD, Holowaty EJ, Miller AB. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type [see comments]. Am J Epidemiol 1993; 138(5): 281-93.
150. Rogers RG, Powell Griner E. Life expectancies of cigarette smokers and non-smokers in the United States. Soc Sci Med 1991; 32(10): 1151-9.
151. Roos LL, Sharp SM, Cohen MM. Comparing clinical information with claims data: some similarities and differences. J Clin Epidemiol 1991; 44: 881-8.
152. Rosenberg L, Kaufman DW, Helmrich SP, Miller DR, Stolley PD, Shapiro S. Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA 1985; 253(20): 2965-9.
153. Rosengren A, Wilhelmsen L, Berglund G, Elmfeldt D. Non-participants in a general population study of men, with special reference to social and alcoholic problems. Acta Med Scand 1987; 221(3): 243-51.
154. Schoenberg JB, Wilcox H, Mason T, Bill J, Stemhagen A. Variation in smoking-related lung cancer risk among New Jersey women. Am J Epidemiol 1989; 130: 688-95.
155. Schroll M. The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): A major international collaboration. J Clin Epidemiol 1988; 41: 105-14.
156. Schroll M, Hansen B, Hansen U, Kirchhoff M, Quitzau S, Schnack H et al. Myokardieinfarktincidensen i Danmark. Resultater fra Dan-Monica 1982-1984. (English summary). Ugeskr Læger 1993; 155: 296-301.
157. Seltzer CC. Framingham study data and "established wisdom" about cigarette smoking and coronary heart disease. J Clin Epidemiol 1988; 42(8): 743-50.
158. Senthilselvan A, Chen Y, Dosman JA. Predictors of asthma and wheezing in adults. Grain farming, sex, and smoking. Am Rev Respir Dis 1993a; 148: 667-70.
159. Senthilselvan A, Dosman JA, Chen Y. Relationship between pulmonary test variables and asthma and wheezing: a validation of self-report of asthma. J Asthma 1993b; 30: 185-93.
160. Shames RS, Heilbron DC, Janson SL, Kishiyama JL, Au DS, Adelman DC. Clinical differences among women with and without self- reported perimenstrual asthma. Ann Allergy Asthma Immunol 1998; 81(1): 65-72.
161. Skobeloff EM, Spivey WH, Clair SS, Schoffstall JM. The influence of age and sex on asthma admissions. JAMA 1992; 268: 3437-40.
162. Skobeloff EM, Spivey WH, Silverman R, Eskin BA, Harchelroad F, Alessi TV. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern Med 1996; 156: 1837-40.
163. Sorlie PD, Lakatos E, Kannel WB, Celli B. Influence of cigarette smoking on lung function at baseline and at follow-up in 14 years: The Framingham study. J Chron Dis 1987; 40(9): 849-56.
164. Sorlie PD, Kannel WB, O'Connor GT. Mortality associated with respiratory function and symptoms in advanced age. Am Rev Respir Dis 1989; 140: 379-84.
165. Sparrow D, O'Connor G, Colton T, Barry CL, Weiss ST. The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function. Am Rev Respir Dis 1987; 135: 1255-60.
166. Speizer FE, Fay ME, Dockery DW, Ferris BGJ. Chronic obstructive pulmonary disease mortality in six U.S. cities. Am Rev Respir Dis 1989; 140: S49-55.
167. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study [see comments]. N Engl J Med 1991; 325(11): 756-62.
168. StataCorp. Stata Statistical Software: Release 4.0.College Station: Texas: Stata Corporation; 1995.
169. StataCorp. Stata Statistical Software: Release 5.0.College Station: Texas: Stata Corporation; 1997.
170. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 1996; 96(10): 1027-39.
171. Storm HH. Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol 1988; 17: 44-9.
172. Strandberg TE, Salomaa VV, Vanhanen HT, Naukkarinen VA, Sarna SJ, Miettinen TA. Mortality in participants and non-participants of a multifactorial prevention study of cardiovascular diseases: a 28 year follow up of the Helsinki Businessmen Study. Br Heart J 1995; 74: 449-54.
173. Suadicani P, Hein HO, Gyntelberg F. Serum validated tobacco use and social inequalities in risk of ischaemic heart disease. Int J Epidemiol 1994; 23: 293-300.
174. Sunyer J, Antó JM, Kogevinas M, Soriano JB, Tobías A, Munoz A et al. Smoking and bronchial responsiveness in non-atopic and atopic young adults. Thorax 1997; 52: 235-8.
175. Sunyer J, Antó JM, McFarlane D, Domingo A, Tobías A, Barceló M et al. Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 851-6.
176. Tabona M, Chan-yeung M, Enarson D, MacLean L, Dorken E, Schulzer M. Host factors affecting longitudinal decline in lung spirometry among grain elevator workers. Chest 1985; 85: 782-6.
177. Tan KS, McFarlane LC, Lipworth BJ. Modulation of airway reactivity and peak flow variability in asthmatics receiving the oral contraceptive pill. Am Rev Respir Dis 1997; 155: 1273-7.
178. Tashkin DP, Altose MD, Bleecker ER, Connett JE, Kanner RE, Lee WW et al. The Lung Health Study: Airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. Am Rev Respir Dis 1992; 145: 301-10.
179. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med 1996; 153(6 Pt 1): 1802-11.
180. Taylor RG, Joyce H, Gross E, Holland F, Pride NB. Bronchial reactivity to inhaled histamine and annual rate of decline in FEV1 in male smokers and ex-smokers. Thorax. 1985; 40: 9-16.
181. The writing group for the PEPI trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995; 273: 199-208.
182. Thun MJ, Day Lally CA, Calle EE, Flanders WD, Heath CW, Jr. Excess mortality among cigarette smokers: changes in a 20-year interval [see comments]. Am J Public Health 1995; 85 (9): 1223-30.
183. Todd G. Medicine - Statistics of smoking in the member states of the European community.Luxembourg: 1986.
184. Torén K, Brisman J, Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest 1993; 104: 600-8.
185. Trap-Jensen J. Effects of smoking on the heart and peripheral circulation. Am Heart J 1988; 115: 263-7.
186. Troisi RJ, Speizer FE, Willett WC, Trichopoulos D, Rosner B. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma: a prospective cohort study. Am J Respir Crit Care Med 1995; 152: 1183-8.
187. Tunstall-Pedoe H, Woodward M, Tavendale R, A'Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study. BMJ 1997; 315: 722-9.
188. Tverdal A, Thelle D, Stensvold I, Leren P, Bjartveit K. Mortality in relation to smoking history: 13 years' follow-up of 68,000 Norwegian men and women 35-49 years. J Clin Epidemiol 1993; 46(5): 475-87.
189. U.S. Department of health and human services. Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General. Rockville, Maryland 20857. Centers for Disease Control. 1989.
190. U.S.Departmenl of health and human services. National Heart, Lung, and Blood Institute Report of the Task Force on Research in Epidemiology and Prevention of Cardiovascular Diseases. Public Health Service National Institutes of Health. 1994.
191. Utell MJ, Samet JM, Bates DV, Becklake MR, Dockery DW, Leaderer BP et al. Air pollution and health. Am Rev Respir Dis 1988; 138: 1065-8.
192. van Pelt W, Borsboom GJJM, Rijcken B, Schouten JP, van Zomeren BC, Quanjer PH. Discrepancies between longitudinal and cross-sectional change in ventilatory function in 12 years of follow-up. Am J Respir Crit Care Med.1994; 149: 1218-26.
193. Vestbo J, Knudsen KM, Rasmussen FV. The value of mucus hypersecretion as a predictor of mortality and hospitalization. An 11-year register based follow-up study of a random population sample of 876 men. Respir Med 1989a; 83: 207-11.
194. Vestbo J, Rasmussen FV. Respiratory symptoms and FEV1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease. Eur Respir J 1989b; 2: 710-5.
195. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Am J Respir Crit Care Med 1996; 153: 1530-5.
196. Vestbo J, Prescott E. Update on the "Dutch hypothesis" for chronic respiratory disease. Thorax 1998; 53 (suppl.2): S15-9.
197. Vesterinen E, Kaprio J, Koskenvuo M. Prospective study of asthma in relation to smoking habits among 14,729 adults. Thorax 1988; 43: 534-9.
198. Viegi G, Paoletti P, Prediletto R, Carrozzi L, Fazzi P, Di Pede F et al. Prevalence of respiratory symptoms in an unpolluted area of Northern Italy. Eur Respir J 1988; 1: 311-8.
199. Viegi G, Baldacci S, Vellutini M, Carrozzi L, Modena P, Pedreschi M et al. Prevalence rates of diagnosis of asthma in general population samples of northern and central Italy. Monaldi Arch Chest Dis 1994; 49: 191-6.
200. Vollmer WM, Johnson LR, Buist AS. Relationship of response to a bronchodilator and decline in forced expiratory volume in one second in population studies. Am Rev Respir Dis 1985; 132: 1186-93.
201. Wald N, Baron J. Wald N and Baron J, editors. Smoking and hormone-related disorders. Oxford: Oxford University Press; 1990.
202. Walker M, Shaper AG, Cook DG. Non-participation and mortality in a prospective study of cardiovascular disease. J Epidemiol Community Health 1987; 41: 295-9.
203. Ware JH, Dockery DW, Louis TA, Xu XP, Ferris BG, Jr., Speizer FE. Longitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adults. Am J Epidemiol 1990; 132(4): 685-700.
204. Weinmann GG, Zacur H, Fish JE. Absence of changes in airway responsiveness during the menstrual cycle. J Allergy Clin Immunol 1987; 79: 1039-42.
205. Weiss ST, Ware JH. Overview of issues in the longitudinal analysis of respiratory data. Am J Respir Crit Care Med 1996; 154: S208-11.
206. Wilhelmsen L, Ljungberg S, Wedel H, Werkö L. A comparison between participants and non-participants in a primary prevention trial. J Chron Dis 1976; 29: 331-9.
207. Willett WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317(21): 1303-9.
208. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990; 81: 1680-7.
209. Wilson PW, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med 1985; 313(17): 1038-43.
210. World Health Organisation. Tobacco or health: A global status report. Geneva: World Health Organization; 1997.
211. Xu X, Dockery DW, Ware JH, Speizer FE, Ferris BG, Jr. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis 1992; 146: 1345-8.
212. Xu X, Li B, Wang L. Gender difference in smoking effects on adult pulmonary function. Eur Respir J 1994a; 7: 477-83.
213. 1: new insight into gender differences. Eur Respir J 1994b; 7: 1056-61.
214. Xu X, Laird N, Dockery DW, Schouten JP, Rijcken B, Weiss ST. Age, period, and cohort effects on pulmonary function in a 24-year longitudinal study. Am J Epidemiol. 1995; 141: 554-566.
215. Xu X, Rijcken B, Schouten JP, Weiss ST. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997; 350: 1431-4.
216. Zang EA, Wynder EL. Cumulative tar exposure. A new index for estimating lung cancer risk among cigarette smokers. Cancer 1992; 70: 69-76.
217. Ziegler RG, Mayne ST, Swanson CA. Nutrition and lung cancer. Cancer Causes Control 1996; 7: 157-77.
218. østerlind A, Jensen OM. Evaluation of registration of cancer cases in Denmark in 1977. Preliminary evaluation of registration of cancer cases by the cancer register and the National Patient Register (English summary). Ugeskr Læger 1985; 147: 2483-8.